Geoffrey Rose
Vermogen: 595 024 $ op 30-06-2026
Vermogen: 595 024 $ op 30-06-2026
Geoffrey Beran Rose is Chief Commercial Officer at Pulmonx Corp.
since 2020.
Formerly, Mr. Rose was Group Director-Global Marketing at Boston Scientific Corp.
from 2013 to 2014.
Mr. Rose completed undergraduate studies at Yale University and earned an MBA from MIT Sloan School of Management.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PULMONX CORP. 1,08% | 01-06-2026 | 457.711 ( 1,08% ) | 595 024 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PULMONX CORPORATION | Corporate Officer/Principal | 01-01-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Verkoop & Marketing | 01-12-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Boston Scientific Corp.
Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Pulmonx Corp.
Pulmonx Corp. Medical SpecialtiesHealth Technology Develops and manufactures zephyr endobronchial valves for the treatment of emphysema | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau